Document is current
Any future updates will be listed below
-
Authors
Goreis, Andreas https://orcid.org/0000-0001-8994-964X
Lozar, Annika
List, Rosa https://orcid.org/0009-0006-4032-0158
Oehlke, Sofia-Marie
Pfeffer, Bettina
Prillinger, Karin https://orcid.org/0000-0001-9835-1850
Klinger, Diana
Zesch, Heidi
Marschik, Peter B.
Claes, Laurence https://orcid.org/0000-0002-2287-3158
Plener, Paul L.
Kothgassner, Oswald D. https://orcid.org/0000-0002-3243-0238
-
Funding
Funding for this research was provided by:
Austrian Science Fund (KLI963)
Österreichischen Akademie der Wissenschaften (27232)
- License Information
-
More Information
Article History
Received: 13 November 2025
Revised: 22 April 2026
Accepted: 19 May 2026
First Online: 24 May 2026
Competing interests
: PLP serves as an advisor for Boehringer Ingelheim and has received speaker honoraria from GSK, Janssen, Infectopharm, and Oral B. The other authors report no conflicts of interest.
